ATE226594T1 - Peptide abgeleitet aus dem morbillivirus - Google Patents
Peptide abgeleitet aus dem morbillivirusInfo
- Publication number
- ATE226594T1 ATE226594T1 AT97942832T AT97942832T ATE226594T1 AT E226594 T1 ATE226594 T1 AT E226594T1 AT 97942832 T AT97942832 T AT 97942832T AT 97942832 T AT97942832 T AT 97942832T AT E226594 T1 ATE226594 T1 AT E226594T1
- Authority
- AT
- Austria
- Prior art keywords
- morbillivirus
- peptides
- peptides derived
- acid sequence
- disclosed
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C07K16/11—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/18011—Paramyxoviridae
- C12N2760/18411—Morbillivirus, e.g. Measles virus, canine distemper
- C12N2760/18422—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP96112341 | 1996-07-31 | ||
| PCT/EP1997/004070 WO1998005682A2 (en) | 1996-07-31 | 1997-07-26 | Peptides corresponding or imitating at least one antigenic determinant of the hamagglutinin protein of mobillivirus |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE226594T1 true ATE226594T1 (de) | 2002-11-15 |
Family
ID=8223060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT97942832T ATE226594T1 (de) | 1996-07-31 | 1997-07-26 | Peptide abgeleitet aus dem morbillivirus |
Country Status (5)
| Country | Link |
|---|---|
| EP (1) | EP0920449B1 (de) |
| AT (1) | ATE226594T1 (de) |
| AU (1) | AU4452897A (de) |
| DE (1) | DE69716609T2 (de) |
| WO (1) | WO1998005682A2 (de) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2880043A1 (es) * | 2020-05-20 | 2021-11-23 | Fundacion Para El Fomento De La Investig Sanitaria Y Biomedica De La Comunitat Valenciana Fisabio | Peptido para uso en la prevencion y/o tratamiento de una enfermedad causada por un virus que afecta a las vias respiratorias |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP3045581B2 (ja) * | 1991-10-14 | 2000-05-29 | 社団法人北里研究所 | 麻疹ワクチンウイルス株同定方法 |
-
1997
- 1997-07-26 DE DE69716609T patent/DE69716609T2/de not_active Expired - Lifetime
- 1997-07-26 AU AU44528/97A patent/AU4452897A/en not_active Abandoned
- 1997-07-26 EP EP97942832A patent/EP0920449B1/de not_active Expired - Lifetime
- 1997-07-26 AT AT97942832T patent/ATE226594T1/de not_active IP Right Cessation
- 1997-07-26 WO PCT/EP1997/004070 patent/WO1998005682A2/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| EP0920449A2 (de) | 1999-06-09 |
| EP0920449B1 (de) | 2002-10-23 |
| DE69716609D1 (de) | 2002-11-28 |
| AU4452897A (en) | 1998-02-25 |
| WO1998005682A2 (en) | 1998-02-12 |
| DE69716609T2 (de) | 2003-07-03 |
| WO1998005682A3 (en) | 1998-08-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ507378A (en) | Fusion proteins of mycobacterium tuberculosis antigens and their uses | |
| ATE366313T1 (de) | Antigene peptide aus neisseria | |
| GB9215780D0 (en) | Peptide compounds | |
| HU9500270D0 (en) | Conjugates of poorly immunogenic antigens and synthetic peptide carriers and vaccines comprising them | |
| BR9906927A (pt) | Proteìnas de neisseria meningitidis | |
| CA2297786A1 (en) | New immunoprotective influenza antigen and its use in vaccination | |
| ATE70717T1 (de) | Vermehrung der antigenimmunogenizitaet. | |
| WO1995029193A3 (en) | Melanoma antigens | |
| DE69636453D1 (de) | Modulation der aktivität des cholesteryl-ester-transfer-proteins (cetp) | |
| ATE298798T1 (de) | Fusionsproteine zwischen antigene aminosäuresequenzen und beta - 2- mikroglobulin | |
| WO1997026784B1 (en) | Induction of immune response against desired determinants | |
| CA2242878A1 (en) | Induction of immune response against desired determinants | |
| DE69836744D1 (de) | Gruppe a streptokokken-impfstoff | |
| RU95109910A (ru) | Бактериоцины, нуклеотидная последовательность, сигнальный пептид, штамм, способ получения, применение бактериоцина, применение нуклеотидной последовательности | |
| DE69716609D1 (de) | Peptide abgeleitet aus dem morbillivirus | |
| IL109790A0 (en) | Peptides used as carriers in immunogenic constructs suitable for development of synthetic vaccines | |
| NO992158L (no) | Nukleinsyre- og aminosyresekvenser forbundet med Heliobacter Pylori og vaksinepreparater av disse. | |
| DK0762895T3 (da) | Syntetisk vaccine til beskyttelse mod infektion med human immundefektvirus | |
| DE69935599D1 (de) | Modifizierte hcv peptid-impfstoffe | |
| CA2158024A1 (en) | A mycoplasma gallisepticum antigen, dna encoding the antigen, recombinant vector bearing the dna and recombinant virus utilizing the recombinant vector as well as use thereof | |
| CA2128407A1 (en) | Synthetic peptides for a rubella vaccine | |
| WO2000006706A3 (en) | Map kinase phosphatase mutant | |
| PE20010239A1 (es) | Gen derivado de lawsonia y polipeptidos, peptidos y proteinas de hemolisina relacionados y sus usos | |
| WO2000047227A3 (en) | Mycobacterium tuberculosis, immunization | |
| IT1277057B1 (it) | Peptidi antigenici migliorati |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |